Study for Anxiety, Depression, and PTSD Symptoms
This study is testing a computer-based program called COGENT to see if it can improve thinking skills in people with anxiety, depression, or post-traumatic stress disorder (PTSD). You would be randomly assigned to either receive COGENT or a similar program called Sham Program, which researchers believe will be less effective. The study aims to see if COGENT can help reduce repetitive negative thoughts by improving cognitive performance (how well your brain processes information). To join, you need to be between 21 and 55 years old, speak English, have a diagnosis of a mood, anxiety, or traumatic stress disorder, and experience clinically elevated repetitive negative thinking. The study is currently unclear on its recruitment status.
- Study design
- This is an interventional study where 128 participants will be randomly assigned to one of two groups. One group will receive the COGENT program, and the other will receive a Sham Program.
- What's involved
- Your cognitive performance will be measured at the start of the study (Baseline), and again at Week 4, Week 8, and Week 16.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for cognitive performance up to Week 16 after starting the study.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Enhancing Transdiagnostic Mechanisms of Cognitive Dyscontrol (R33)
At a glance
Conditions
Where it's being run
1 sites across 1 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Change in cognitive performanceBaseline, Week 4, Week 8, Week 16
Span Working Memory Score. Scores are calculated based on memory accuracy total points across all trials, with higher scores indicating better performance. This change is expected to be significantly higher for the COGENT group than the Sham group.